- Home
- NBIX vs IEX Comparison
NBIX vs IEX Comparison
Compare NBIX & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- IEX
- Stock Information
- Founded
- NBIX 1992
- IEX 1987
- Country
- NBIX United States
- IEX United States
- Employees
- NBIX N/A
- IEX N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- IEX Fluid Controls
- Sector
- NBIX Health Care
- IEX Industrials
- Exchange
- NBIX Nasdaq
- IEX Nasdaq
- Market Cap
- NBIX 14.4B
- IEX 12.6B
- IPO Year
- NBIX 1996
- IEX 1991
- Fundamental
- Price
- NBIX $150.87
- IEX $167.92
- Analyst Decision
- NBIX Strong Buy
- IEX Strong Buy
- Analyst Count
- NBIX 18
- IEX 5
- Target Price
- NBIX $172.06
- IEX $198.80
- AVG Volume (30 Days)
- NBIX 1.0M
- IEX 666.4K
- Earning Date
- NBIX 10-28-2025
- IEX 10-29-2025
- Dividend Yield
- NBIX N/A
- IEX 1.69%
- EPS Growth
- NBIX 12.44
- IEX N/A
- EPS
- NBIX 4.19
- IEX 6.32
- Revenue
- NBIX $2,682,700,000.00
- IEX $3,421,300,000.00
- Revenue This Year
- NBIX $23.68
- IEX $6.22
- Revenue Next Year
- NBIX $18.02
- IEX $3.11
- P/E Ratio
- NBIX $35.78
- IEX $26.63
- Revenue Growth
- NBIX 19.61
- IEX 7.09
- 52 Week Low
- NBIX $84.23
- IEX $153.36
- 52 Week High
- NBIX $157.67
- IEX $237.38
- Technical
- Relative Strength Index (RSI)
- NBIX 59.16
- IEX 50.68
- Support Level
- NBIX $133.62
- IEX $165.40
- Resistance Level
- NBIX $157.67
- IEX $170.22
- Average True Range (ATR)
- NBIX 4.58
- IEX 3.86
- MACD
- NBIX 0.98
- IEX -0.22
- Stochastic Oscillator
- NBIX 67.98
- IEX 12.63
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2024.